• Vision & goals
• Research
• Production
• Organization
• Management
• Department Directors
• Board of directors
• History

Research and development

The core of Oasmia's research and development is the company's long term strategic investments in nanotechnology. Our ambition to reach new creative solutions permeates not only basic research but all steps of the development process. We are trying to meet the biotechnological demands of the future by always being one step ahead. The company and its staff are always open to new challenges and are eager to integrate new innovative projects in Oasmia's own activity. 

Natural existing low molecular agents play an important roll in the control of biochemical processes. Oasmia is developing new semi-synthetic derivatives of retinoids and polyunsaturated fatty acids. The retinoid derivative-based excipient models will form the basis for our development of new water soluble drugs with reduced side effects, no hypersensitivity reactions and short infusion times all of which resulting in improved quality of life. This technique enables new forms of treatment, not only for the treatment of cancer.

Our investment in the early stages of research has already led to decisive results. We continue our efforts to develop our products and we are convinced that Oasmia's basic ideas will be beneficial for both health care and society in the future.